Crypto News 

Hyperledger’s Behlendorf: 2018 Will Bring Breakthrough Blockchain Developments

“Iroha is a business blockchain framework for infrastructure projects that require the use of distributed ledger technology” writes Jessie Willms for bitcoinmagazine.com. Sawtooth is a blockchain platform for creating and managing distributed ledgers. Indy is a distributed ledger with a decentralized identity designed to create independent digital identities between blockchains. is an open development tool set designed to make it easier to integrate existing business systems with the blockchain.A number of Hyperledger projects are exploring integrations among one another including Hyperledger Sawtooth and Burrow and Indy, Composer and Quilt.” Behlendorf…

Read More
News Regulators 

Euro hits 3-year high on breakthrough for German coalition talks

“December core inflation rose 0.3%, compared with MarketWatch consensus forecast of 0.2%, while headline numbers were in line with estimates at 0.1%” writes Markets Reporter for marketwatch.com. The U.S. dollar meanwhile held the losses it incurred on the back of euro strength, even as data showed that core inflation rose slightly more-than-expected in December.On the year, inflation rose 1.8%, up modestly from 1.7% before. Source: marketwatch.com Share This:

Read More
GBP News 

FTSE 100 edges down as Brexit breakthrough lifts the pound

“But the FTSE 100 was hampered by pound strength, as roughly 75% of revenue for companies listed on the London index is generated overseas” writes Markets Reporter for marketwatch.com. How markets are moving: The FTSE 100 index UKX, +0.29% edged down 1.5 points to 7,319.10, after opening fractionally higher.But the benchmark FTSE 100 was hurt by the rising pound, which gained more strength after the news.Elsewhere, mining shares rose after Chinese exports rose for the ninth straight month, blowing past forecasts. Source: marketwatch.com Share This:

Read More
GBP News 

Pound rallies to 6-month high against euro after Brexit breakthrough

“Those ended early Friday, with Jean-Claude Juncker, president of the European Commission, saying there had been a breakthrough in Brexit talks” writes Markets Reporter for marketwatch.com. Against the dollar GBPUSD, +0.0000%  , the pound initially spiked to an intraday high of $1.3521, but has since slipped back to $1.3499.The pound rallied against all other major currencies on Friday morning, scoring a six-month against the euro, after the U.K. and the European Union came to terms on issues that were holding up the next stage of Brexit talks.The breakthrough reduces the…

Read More
GBP News 

Breakthrough on Brexit terms opens way to next phase of talks

“Jean-Claude Juncker, president of the European Commission, said in a press conference early Friday morning that sufficient progress had been made for the talks to move forward” writes News Editor for marketwatch.com. But on Friday, May indicated that obstacle had been removed overnight, allowing the Brexit process to advance. “There will be no hard border,” May said at the press conference in Brussels. Source: marketwatch.com Share This:

Read More
GBP News 

Pound rises against dollar and euro after major Brexit breakthrough

“The pound rose against a host of currencies on Friday morning, after the European Commission declared that enough progress had been made in Brexit talks to move on to a second phase of negotiations” writes Josie Cox for independent.co.uk. In early trading, sterling was up around 0.3 per cent against the dollar and 0.4 per cent against the euro.It also rose against Japan’s yen, the Swiss franc, the Australian and Canadian dollars and a selection of other world currencies.Stephen Martin, director general of the Institute of Directors agreed. “The most…

Read More
News 

Sage Therapeutics skyrockets more than 60% after depression drug breakthrough

“Shares of Sage Therapeutics soared 75 percent on Thursday after the company announced positive results in the testing a major depressive disorder (MDD) treatment” writes Adam Jeffery for cnbc.com. On Nov. 9, the company said brexanolone — a drug aimed at treating moderate and severe postpartum depression — met its main goal in two late-stage studies. Source: cnbc.com Share This:

Read More